Navigation Links
Swell gel could bring relief to back pain sufferers

Scientists at The University of Manchester believe injections of tiny sponge-like particles could provide an alternative to major surgery in the treatment of chronic lower back pain.

Dr Brian Saunders from The School of Materials and Professor Tony Freemont from The Faculty of Medical and Human Sciences have developed tiny gel particles that swell and stiffen when injected into a damaged area.

Investigations have revealed that degenerated animal intervertebral discs containing the injected 'microgels' regain their mechanical properties.

This development opens up the possibility of human patients being able to regain full mobility and flexibility after receiving spinal injections.

This would compare favourably with spinal fusion - a major surgical procedure with considerable recovery time for the patient, resulting in a significant loss of mobility at the fused and adjacent discs.

Degeneration of intervertebral discs causes holes in the load-bearing tissue of the disc, decreasing disc height and resulting in pain.

The microgel particles the research team have developed are like 'smart sponges' when dispersed in water.

The material is a fluid at a low pH - in other words, a low level of acidity - and can be injected through a syringe. It changes to a stiff gel at physiological pH values - that is, once it enters the body - due to absorption of water by the particles.

During their investigations, the research team injected the material into a damaged bovine intervertebral disc and increased the pH to biological levels by injecting an alkaline solution.

Professor Freemont, who works in the Division of Regenerative Medicine in the School of Medicine, said: "This research was motivated by the urgent need for a non-surgical method for repairing intervertebral discs.

"Our approach has the advantage of restoring spinal mobility whereas spinal fusion surgery results in a signific ant loss of mobility at the fused and adjacent discs."

Dr Saunders said: "Although we are encouraged by our findings, much work lies ahead to develop a viable non-surgical repair technology to replace spinal fusion as the standard surgical treatment for chronic lower back pain."

He added that future work will investigate biodegradable microgels that release additives to stimulate regeneration of intervertebral disc tissue.


'"/>

Source:University of Manchester


Related biology news :

1. Protein discovery could unlock the secret to better TB treatment
2. Tiny particles could solve billion-dollar problem
3. First atlas of key brain genes could speed research on cancer, neurological diseases
4. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
5. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
6. How the environment could be damaging mens reproductive health
7. Dead zone area in Gulf could be increasing, researchers say
8. Growth in biomass could put US on road to energy independence
9. Nano-bumps could help repair clogged blood vessels
10. Researchers develop assay that could be applied to drug screening
11. Currents could disrupt ocean food chain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology: